ArticleBMC microbiology2025
In vitro and in vivo investigation of the antibacterial, antivirulence, and antiquorum sensing activities of β-carotene against difficult-to-treat resistant Pseudomonas aeruginosa.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Eco-Friendly Extraction and Valorization of Cucumis metuliferus E. Mey. ex Naud. Peel and Pulp: Optimization of Phenolic Recovery and Evaluation of Biological Activities.Chemistry & biodiversity · 2026Article
- In Silico and In-vitro assessment of β carotene extracted from Westella botryoides for fighting multidrug resistant bacterial strains.International microbiology : the official journal of the Spanish Society for Microbiology · 2026Article
- SIRT1 mediated autophagy enhancement by Lactobacillus fermentum derived oligosaccharides accelerates wound healing in biofilm associated infection.Scientific reports · 2025Article
- The dual antifungal and antibiofilm activities of β-carotene against multidrug-resistant Candida albicans induce wound healing in a diabetic rat model: an in vitro and in vivo study.BMC microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDifficult-to-treat resistant (DTR) Pseudomonas aeruginosa has strong drug resistance and can tolerate a diversity of antibiotics. Infections triggered by DTR P. aeruginosa urgently require research and development of innovative antibiotics. β-Carotene is a carotenoid pigment with multiple activities, such as antibacterial, antifungal, antioxidant, and anticancer activities, therefore, the current study aimed to investigate the potential antipseudomonal activity of β-carotene against DTR P. aeruginosa to find a new treatment option.
methodsAntimicrobial susceptibility tests were conducted for 100 P. aeruginosa isolates. Well diffusion and broth microdilution techniques were utilized to determine the antibacterial activity of β-carotene. A total of 10 virulence factors (biofilm, pyocyanin, motility, protease, gelatinase, exopolysaccharide, siderophore, hemolysin, pyomelanin, and rhamnolipid) were screened among the tested isolates, and the effect of β-carotene on these virulence factors was assessed. Light microscopy and confocal laser scanning microscopy approaches were established to investigate the effect of β-carotene on biofilm formation by DTR isolates. Molecular analysis, docking study, and the wound infection model further evaluated the antipseudomonal action of β-carotene against DTR isolates.
resultsAll tested multidrug-resistant (MDR) and DTR isolates (n = 40) were susceptible to β-carotene (200 µg/ml), with inhibition zones ranging from 10 to 33 mm, recording minimum inhibitory concentration (MIC) values of 12.5 to 100 µg/ml. It was reported that β-carotene reduced the production of all tested virulence factors by DTR isolates, and the percentages of inhibition ranged from 21.5 to 100%. Additionally, β-carotene-treated biofilms showed a significant reduction in biomass and thickness (up to 60%). Moreover, the production of virulence-associated genes, namely lasR, rhlR, and pqsR genes, was downregulated by 0.5 MIC of β-carotene. The molecular docking displayed a resilient LasR-β-carotene complex with a binding free energy of -8.6 kcal/mol. The β-carotene-treated rat group showed accelerated wound closure (up to 90% at day 6) and lower Pseudomonas burden (3.3 colony forming unit/g). In addition, the histological examination showed re-epithelialization in the epidermis layer with a few capillaries and newly formed hair follicles in the treated group.
conclusionThis is the first study to report the antibacterial, antivirulence, and antiquorum sensing activities of β-carotene against DTR P. aeruginosa, signifying the promising role of β-carotene in mitigating DTR P. aeruginosa-caused infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.